The treatment of Peyronie's disease with ACTH; preliminary report
Sanjurjo, L.A.
Boletin de la Asociacion Medica de Puerto Rico 44(8): 320-325
1952
ISSN/ISBN: 0004-4849 PMID: 12977841 Document Number: 702219
Document emailed within 1 workday
Related Documents
Treffiletti, S.; Annoscia, S.; Montefiore, F.; Boccafoschi, C. 1997: Iontophoresis in the conservative treatment of Peyronie's disease: preliminary experience Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 69(5): 323-327Zgliczyński, S.; Kozłowicz, I.; Wilczyńska, J.; Baranowska, B. 1980: Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report Materia Medica Polona. Polish Journal of Medicine and Pharmacy 12(1-2): 85-90
Prasad, M.; Pradhan, P.K. 1971: Peyronie's disease--report of four cases Indian Journal of Pathology and Bacteriology 14(4): 180-183
Hisamatsu, E.; Naoi, M.; Ota, T.; Tsukamoto, S.; Shimazui, T.; Takeshima, H.; Akaza, H. 2002: Saphenous vein grafting for Peyronie's disease: a case report Hinyokika Kiyo. Acta Urologica Japonica 48(5): 285-288
Krylov, V.S.; Novak, G.I.; Abalmasov, K.G. 1986: Surgical treatment of Peyronie's disease Khirurgiia 12: 84-90
Khouaja, K.; Delmas, V.; Boccon-Gibod, L. 2004: Leriche technique for the treatment of la Peyronie's disease Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 14(4): 586-589; Discussion: 588-589
Bartsch, G.; Menander-Huber, K.B.; Huber, W.; Marberger, H. 1981: Orgotein, a new drug for the treatment of Peyronie's disease European Journal of Rheumatology and Inflammation 4(2): 250-259
Paladini, G. 1981: Peyronie's disease and systemic lupus erythematosus syndrome associated with metoprolol administration: a case report International Journal of Tissue Reactions 3(2): 95-98
Arena, F.; Peracchia, G.; Di Stefano, C.; Passari, A.; Larosa, M.; Cortellini, P. 1995: Clinical effects of verapamil in the treatment of Peyronie's disease Acta Bio-Medica de l'Ateneo Parmense 66(6): 269-272
Lin, H.-C.; Zhang, H.-T.; Jiang, H. 2017: Collagenase clostridium histolyticum for Peyronie's disease: a new minimally invasive and effective treatment Zhonghua Nan Ke Xue 23(9): 771-775
Egydio, P.H. 2008: Surgical treatment of Peyronie's disease: choosing the best approach to improve patient satisfaction Asian Journal of Andrology 10(1): 158-166
Syskov, I.V.; Romanovskiĭ, P.I.; Vosekalna, I.A.; Skuin'sh, A.A.; Ratkevich, M.P. 1984: Structural and functional organization of ACTH: synthesis and properties of analogs of ACTH-(11-24)-tetradeca- and ACTH-(1-24)-tetracosapeptides containing hexa-amino acids instead of a natural sequence of ACTH 19-24 amino acids Bioorganicheskaia Khimiia 10(5): 618-625
Fiszer, U. 1989: Study of the immunologic status of persons with Parkinson disease with special reference to the effect of levodopa treatment. Preliminary report Neurologia i Neurochirurgia Polska 23(1): 7-11
Saigal, S.; Agarwal, S.R.; Nandeesh, H.P.; Sarin, S.K. 2001: Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: A preliminary report Journal of Gastroenterology and Hepatology 16(9): 1028-1032
Pilipović-Ećim, V.; Mrda, S. 1989: Peyronie's disease Acta Chirurgica Iugoslavica 36(Suppl 2): 782-784
Devine, C.J.; Somers, K.D.; Ladaga, L.E. 1991: Peyronie's disease: pathophysiology Progress in Clinical and Biological Research 370: 355-358
Bodner, H. 1978: Peyronie's disease revisited International Surgery 63(6): 69-71
Bartolin, Z.; Sipus, I.; Bartolin, V. 1983: Corpus cavernosography in Peyronie's disease Lijecnicki Vjesnik 105(6): 247-250
Princivalle, M.; Simone, M.; De Luca, C.; Scutellari, P.N.; Giganti, M.; Reggiani, A.; Piffanelli, A. 1989: Echographic diagnosis of Peyronie's disease La Radiologia Medica 78(1-2): 74-78
Zhao, F.; Li, H. 2004: Advances in the research of Peyronie's disease Zhonghua Nan Ke Xue 10(5): 378-381